
|Articles|February 1, 2011
- Pharmaceutical Executive-02-01-2011
- Volume 0
- Issue 0
Pharmaceutical Executive Digital Edition - February 2011
The Promise Of Translational Medicine
Advertisement
Articles in this issue
about 15 years ago
Skipping the Needle: Pharm Exec's Brand of the Yearabout 15 years ago
Honing Reforms from Clinical Developmentabout 15 years ago
Growing Stronger After the StormNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Novo Nordisk Releases 2025 Financial Report and 2026 Sales and Operations Profit Outlook
2
Eli Lilly Announces New $3.5 Billion Manufacturing Facility in Pennsylvania
3
Novartis’ Q4 Recap Shows Signs of Looming Patent Cliff
4
FDA Rejects AstraZeneca’s Application for Subcutaneous Indication of Saphnelo
5



